Protective effect of Panax quinquefolium 20(S)‑protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats

Xu,Huali; Yu,Xiaofeng; Qu,Shaochun; Chen,Yangping; Wang,Zhicai; Sui,Dayun

doi:10.3892/etm.2013.1405

Protective effect of Panax quinquefolium 20(S)‑protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats

Authors:
- Huali Xu
- Xiaofeng Yu
- Shaochun Qu
- Yangping Chen
- Zhicai Wang
- Dayun Sui
View Affiliations

Affiliations: Department of Pharmacology, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China, Department of Natural Medicinal Chemistry, School of Chemistry, Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: November 12, 2013 https://doi.org/10.3892/etm.2013.1405
Pages: 165-170

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oxidative stress is significant in the pathogenesis of cerebral ischemia. Panax quinquefolium 20(S)‑protopanaxadiol saponins (PQDS) have been demonstrated to exhibit a variety of biological effects in the cardiovascular system as a result of their antioxidant properties. However, little is known regarding the effect of PQDS on cerebral ischemia. The purpose of this study was to investigate whether PQDS exhibited protective effects against cerebral ischemia. A model of cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) in Sprague‑Dawley rats. Adult male rats were randomly divided into five groups: Sham, MCAO and PQDS treatment groups at doses of 12.5, 25.0 and 50.0 mg/kg. The effects of PQDS on neurological deficits, cerebral infarct area, brain water content, and the malondialdehyde (MDA) and Ca2+ levels and Na+‑K+‑ATPase and superoxide dismutase (SOD) activities in the brain tissue were analyzed, and the nitric oxide (NO) content and nitric oxide synthase (NOS) activity in the serum were evaluated. Moreover, the expression of Bcl‑2 was analyzed using western blotting. Pretreatment with PQDS (25.0 and 50.0 mg/kg) significantly reduced the neurological deficit score, decreased the infarcted area and decreased the brain water content from 83.09 to 80.27% (P<0.05). In addition, PQDS pretreatment decreased the NOS activity and the NO levels in the serum compared with those in the MCAO group. Furthermore, pretreatment with PQDS (25.0 and 50.0 mg/kg) significantly increased the activities of SOD and Na+‑K+‑ATPase and decreased the levels of Ca2+ and MDA in the brain tissue (P<0.05) compared with those in the MCAO group. Pretreatment with PQDS (25.0 and 50.0 mg/kg) also increased the protein expression level of Bcl‑2 compared with that in the MCAO group. The histopathological results demonstrated the protective effect of PQDS on ischemic injury. The results indicated that PQDS has protective effects against ischemic injury in rats. The mechanism may be associated with the inhibition of oxidative stress and apoptosis.

View Figures

View References

1	Zhang HL, Xu M, Wei C, Qin AP, Liu CF, Hong LZ, Zhao XY, Liu J and Qin ZH: Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway. Neuroscience. 176:381–395. 2011.PubMed/NCBI
2	Barone FC: Ischemic stroke intervention requires mixed cellular protection of the penumbra. Curr Opin Investig Drugs. 10:220–223. 2009.PubMed/NCBI
3	Mehta SL, Manhas N and Raghubir R: Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev. 54:34–66. 2007. View Article : Google Scholar : PubMed/NCBI
4	Cui L, Zhang X, Yang R, Wang L, Liu L, Li M and Du W: Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain Res. 1325:164–173. 2010. View Article : Google Scholar : PubMed/NCBI
5	Warner DS, Sheng H and Batinić-Haberle I: Oxidants, antioxidants and the ischemic brain. J Exp Biol. 207:3221–3231. 2004. View Article : Google Scholar : PubMed/NCBI
6	Liu Y, Zhang XJ, Yang CH and Fan HG: Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression. Brain Res. 1268:174–180. 2009. View Article : Google Scholar : PubMed/NCBI
7	Kim H: Neuroprotective herbs for stroke therapy in traditional eastern medicine. Neurol Res. 27:287–301. 2005. View Article : Google Scholar : PubMed/NCBI
8	Li G and Wang Z, Sun Y, Liu K and Wang Z: Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells. Basic Clin Pharmacol Toxicol. 98:588–592. 2006. View Article : Google Scholar : PubMed/NCBI
9	Nishijo H, Uwano T, Zhong YM and Ono T: Proof of the mysterious efficacy of ginseng: basic and clinical trials: effects of red ginseng on learning and memory deficits in an animal model of amnesia. J Pharmacol Sci. 95:145–152. 2004. View Article : Google Scholar
10	Shin JY, Song JY, Yun YS, Yang HO, Rhee DK and Pyo S: Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol Immunotoxicol. 24:469–482. 2002. View Article : Google Scholar : PubMed/NCBI
11	Wang LC and Lee TF: Effect of ginseng saponins on cold tolerance in young and elderly rats. Planta Med. 66:144–147. 2000. View Article : Google Scholar : PubMed/NCBI
12	Beveridge TH, Li TS and Drover JC: Phytosterol content in American ginseng seed oil. J Agric Food Chem. 50:744–750. 2002. View Article : Google Scholar : PubMed/NCBI
13	Xu H, Yu X, Qu S, Chen Y, Wang Z and Sui D: In vive and in vitro cardioprotective effects of panax quinquefolium 20(S)-protopanaxadiol saponins (PQDS), isolated from panax quinquefolium. Pharmazie. 68:287–292. 2013.PubMed/NCBI
14	Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
15	Lee EJ, Chen HY, Wu TS, Chen TY, Ayoub IA and Maynard KI: Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats. J Neurosci Res. 68:636–645. 2002.
16	Li Y, He D, Zhang X, Liu Z, Zhang X, Dong L, Xing Y, Wang C, Qiao H, Zhu C and Chen Y: Protective effect of celastrol in rat cerebral ischemia model: down-regulating p-JNK, p-c-Jun and NF-κB. Brain Res. 1464:8–13. 2012.PubMed/NCBI
17	Vakili A, Kataoka H and Plesnila N: Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 25:1012–1019. 2005. View Article : Google Scholar : PubMed/NCBI
18	Cheyuo C, Jacob A, Wu R, et al: Recombinant human MFG-E8 attenuates cerebral ischemic injury: its role in anti-inflammation and anti-apoptosis. Neuropharmacology. 62:890–900. 2012. View Article : Google Scholar : PubMed/NCBI
19	Noh SJ, Lee SH, Shin KY, Lee CK, Cho IH, Kim HS and Suh YH: SP-8203 reduces oxidative stress via SOD activity and behavioral deficit in cerebral ischemia. Pharmacol Biochem Behav. 98:150–154. 2011. View Article : Google Scholar : PubMed/NCBI
20	Dinkova-Kostova AT and Talalay P: Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res. 52(Suppl 1): S128–S138. 2008.PubMed/NCBI
21	Yin J, Tu C, Zhao J, Ou D, Chen G, Liu Y and Xiao X: Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats. Brain Res. 1491:188–196. 2013. View Article : Google Scholar
22	Ban JY, Cho SO, Choi SH, Ju HS, Kim JY, Bae K, Song KS and Seong YH: Neuroprotective effect of Smilacis chinae rhizome on NMDA-induced neurotoxicity in vitro and focal cerebral ischemia in vivo. J Pharmacol Sci. 106:68–77. 2008.
23	Kristian T and Siesjo BK: Calcium in ischemic cell death. Stroke. 29:705–718. 1998. View Article : Google Scholar : PubMed/NCBI
24	Martinou JC and Youle RJ: Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
25	Nakka VP, Gusain A, Mehta SL and Raghubir R: Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol. 37:7–38. 2008. View Article : Google Scholar : PubMed/NCBI